Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Pharmascience Invests US$120 million to Expand Sterile Injectable Manufacturing Facility in Canada
Pharmascience invests US$120 million to expand its sterile injectable manufacturing facility in Candiac site
National Resilience Invests US$225 million to Increase Cartridge Fill/Finish Capabilities in Cincinnati, USA
National Resilience plans to invest US$225 million to increase PFS and Cartridge fillfinish capabilities in Cincinnati, USA
Daiichi Sankyo Invests US$1.12 billion (€1 billion) to Expand Innovation Centre in Munich, Germany
Daiichi Sankyo with an investment of US$112 billion plans to expand production and development site in Pfaffenhofen an daer Ilm in Germany
Bristol Myers Squibb Invests US$400 million to Expand Sterile Drug Product Facility in Dublin, Ireland
Bristol Myers Squibb invests US$400 million to expand its campus in Dublin, Ireland, by incorporating a new sterile drug product facility
SCHOTT Pharma Plans to Open New Production Facility in Jagodina, Serbia
SCHOTT Pharma is investing a multimillioneuro investment to open a stateoftheart production facility for pharmaceutical drug containment solutions and delivery systems in Jagodina, Serbia
AstraZeneca Invests US$300 million to Open New Manufacturing Facility in Maryland, USA
AstraZeneca invests US$300 million to open a stateoftheart manufcaturing facility in Maryland, USA The Rockville facility aims to enhance its manufacturing
AbbVie Invests US$223 million to Expand Biologics Manufacturing Site in Singapore
AbbVie invests US$223 million to expand biologics manufacturing capacity in Singapore
Sai Life Sciences Expands its Laboratory Capabilities in India
Sai Life Sciences expands its DMPK capabilities The expansion of DMPK capabilities augments integrated drug discovery offerings in India
APC and VLE Therapeutics Invests US$108 million (€100 million) to Open Medicine Campus in Dublin, Ireland
APC and VLE Therapeutics are investing US$108 million 100 million for the groundbreaking expansion of medicine accelerator campus in Dublin, Ireland
Genevoyager Plans for the Construction of New Gene Therapy CDMO Facility in USA
Genevoyager unveils stateoftheart gene therapy contract development and manufacturing organisation CDMO facility in USA The newly inaugurated cGMP facility boasts stateoftheart infrastructure
